Christina T. Roupas

Cooley advised NETSTREIT on $275.0 million in additional financing commitments and amendments to its existing credit facilities, agented by PNC Bank, National Association; Wells Fargo Bank, National Association; and Truist Bank. NETSTREIT is a Dallas-based real estate investment trust that acquires single-tenant net lease retail properties across the US. Partner Addison Pierce led the Cooley team advising NETSTREIT, which included partners Christina Roupas and Todd Gluth and associates Margaret Barreto and Cam Irwin.

Cooley advised Tempus AI (Nasdaq: TEM), a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, on its agreement to acquire Ambry Genetics, a company focusing on genetic testing that aims to improve health by understanding the relationship between genetics and disease.

Cooley advised PetIQ (Nasdaq: PETQ), a leading pet medication, health and wellness company, on its definitive merger agreement with Bansk Group, pursuant to which Bansk Group will acquire all outstanding shares of PetIQ’s common stock for $31 per share in an all-cash transaction valued at approximately $1.5 billion.

Cooley advised Alto Neuroscience, a company redefining psychiatry by leveraging individuals’ neurobiology to develop personalized and highly effective medicines and helping patients get better faster, on its $147.9 million initial public offering.

Cooley advised COUR Pharmaceuticals, a clinical-stage biotechnology company focused on the development of first-in-class disease-modifying therapies designed to induce antigen-specific tolerance for immune-mediated diseases, on the close of its $105 million Series A financing.